Clinical Trial Update: FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating FDG-PET directed treatment for locally advanced gastric and gastroesophageal junction adenocarcinoma was terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2019-09-11